IR – Overview

Zynex Investor Relations

Symbol: ZYXI


September 2017
Investor Presentation


Zynex Inc. was founded in 1996 on the principle that a commitment to high-quality patient life through non-invasive rehabilitation products can be a profitable as well as rewarding endeavor.

Today, Zynex is a leading provider of electrotherapy medical devices used for pain management and rehabilitation. The company’s proprietary NeuroMove device is used to help recovery of stroke and spinal cord injury patients. Zynex is also pioneering development of an innovative blood volume monitor for use in hospitals and surgery centers. Zynex is committed to improve the quality of life of patients in the markets it serves by providing the highest technology and service standards available in the industry.


Press Releases


July 2016 Investor Newsletter

Zynex 2015 Year End Earnings Conference Call




LONE TREE, Colo., June 19, 2017 /PRNewswire/ — Zynex (OTCQB: ZYXI), an innovative medical technology company specializing in the manufacture and sale of non-invasive medical devices for pain management, stroke rehabilitation, neurodiagnostic equipment, cardiac and blood volume monitoring, announces today that ColoradoBiz Magazine has recognized Zynex in Top100 Public Companies in its May/June 2017 issue.

READ MORE

2013 – Zynex Ranked 15th in Revenue Growth
Among Medical Device Companies


2012 – Zynex Ranked 7th in Revenue Growth
Among Medical Device Companies


2011 – Zynex Ranked 9th in Revenue Growth
Among Medical Equipment Companies


2010 – Zynex Ranked 8th in Growth Among
Medical Equipment Companies


Research & Analysis

Media

Investor Newsletters

SEC Filings